Published in Cancer on September 01, 1981
The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg (1991) 1.05
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters. Br J Cancer (1992) 0.80
Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. Korean J Intern Med (1996) 0.77
Studies on the chemotherapy with 5-fluorouracil in transcatheter arterial chemoembolization (TAE) treated patients with resectable or non-resectable hepatocellular carcinoma. Osaka Study Group on Hepatocellular Carcinoma. Cancer Chemother Pharmacol (1989) 0.75
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis (2002) 3.31
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med (1984) 2.76
Sudden death in asthma. Thorax (1979) 2.72
The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood (1969) 2.61
Prostitutes and AIDS: a health department priority? Am J Public Health (1988) 2.56
A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol (1980) 2.55
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol (2000) 2.39
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Environmental PCB exposure and risk of endometriosis. Hum Reprod (2004) 2.17
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Coagulation defects associated with massive blood transfusions. Ann Surg (1971) 2.03
Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med (1984) 1.90
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med (1971) 1.89
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest (1974) 1.85
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol (1987) 1.85
Urinary retention and intestinal obstruction associated with ano-rectal Herpes simplex virus infection. Br Med J (1975) 1.83
Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med (1995) 1.79
Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer (1991) 1.78
Meeting the challenge of developing and maintaining radical hysterectomy skills. BJOG (2010) 1.71
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Metastatic and histologic presentations in unknown primary cancer. Semin Oncol (1977) 1.61
Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother Rep (1975) 1.58
Septic complications of war wounds. JAMA (1972) 1.58
Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA (1979) 1.57
Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine. JAMA (1988) 1.56
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol (1979) 1.54
Access to data and the information explosion: oral contraceptives and risk of cancer. Contraception (1981) 1.52
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50
Comparison of information processing technologies. J Am Med Inform Assoc (2001) 1.50
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Reported food intolerance and respiratory symptoms in young adults. Eur Respir J (1998) 1.44
Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy: a quantitative computed tomography study. Arch Ophthalmol (1982) 1.44
Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics (1982) 1.44
Allergen immunotherapy for asthma. Cochrane Database Syst Rev (2003) 1.41
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother (1996) 1.41
Vega testing in the diagnosis of allergic conditions. The Australian College of Allergy. Med J Aust (1991) 1.40
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J Gastroenterol Hepatol (2000) 1.40
Primary percutaneous coronary intervention for ST elevation myocardial infarction: performance with focus on timeliness of treatment. Hong Kong Med J (2010) 1.40
Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy. Arch Ophthalmol (1984) 1.39
The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology (1999) 1.39
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38
Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38
Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy. Arch Ophthalmol (1985) 1.37
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrob Agents Chemother (1989) 1.32
Clinical and bacteriological evaluation of antibiotic treatment in shigellosis. JAMA (1970) 1.29
Ambipolar electrical transport in semiconducting single-wall carbon nanotubes. Phys Rev Lett (2001) 1.29
Duration and death in systemic lupus erythematosus. An analysis of 249 cases. JAMA (1974) 1.28
Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol (2001) 1.28
Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols. J Lab Clin Med (1973) 1.27
Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. Osteoporos Int (2008) 1.25
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells. Leukemia (2003) 1.23
Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol (1996) 1.21
XK469, a selective topoisomerase IIbeta poison. Proc Natl Acad Sci U S A (1999) 1.21
Monitoring dietary change in a low-fat diet intervention study: advantages of using 24-hour dietary recalls vs food records. J Am Diet Assoc (1996) 1.18
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat (1986) 1.17
Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG). Cancer (1971) 1.17
Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology (1981) 1.15
Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep (1978) 1.15
Absolute configurations of the four warfarin alcohols. J Med Chem (1972) 1.15
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Gas gangrene infection of the eyes and orbits. Br J Ophthalmol (1985) 1.14
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A genetic association with the development of alcohol and other substance use behavior in Asian Americans. J Abnorm Psychol (2001) 1.13
Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology (1986) 1.13
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13
5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases. Cancer (1977) 1.13
5-fluorouracil given once weekly: comparison of intravenous and oral administration. Cancer (1971) 1.12
A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory. Drug Metab Dispos (1983) 1.12
Hypogonadism in male patients with metastatic cancer prior to chemotherapy. Cancer Res (1982) 1.11
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia (2012) 1.11
Topoisomerase II poisoning by ICRF-193. J Biol Chem (2001) 1.10
Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax (1979) 1.10
Tracing expert thinking in clinical trial design. Comput Biomed Res (1989) 1.09
Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology (1986) 1.08
Suicide in Hong Kong: a case-control psychological autopsy study. Psychol Med (2006) 1.08
Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer. Cancer Treat Rep (1986) 1.08
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
Alterations in the immune response of nonresponders to the hepatitis B vaccine. J Infect Dis (1985) 1.07
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb) (2001) 1.06
Metabolic abnormalities in the cancer patient. Cancer (1985) 1.06
Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1. Gene (1999) 1.05
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. Cancer Treat Rep (1984) 1.05